Observational studyMedicine2025
Retrospective evaluation of active tuberculosis cases in terms of chemoprophylaxis indication: A cross-sectional study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we retrospectively evaluated the indications for chemoprophylaxis in active tuberculosis cases and reviewed the risk of latent tuberculosis infection (LTBI) progressing to active disease. Along with our decisions regarding LTBI treatment indications, we aimed to determine whether there were any shortcomings in this area. This study included 422 tuberculosis patients who were registered at the Provincial Central Tuberculosis Control Dispensary and diagnosed between 2016 and 2020. This was a single-center retrospective clinical study. These patients were evaluated in terms of latent tuberculosis treatment indication criteria in the Tuberculosis Diagnosis and Treatment Guide before they became patients with tuberculosis. All radiological images of the patients were evaluated. A total of 422 patients were included in this study. Of these, 147 (34.8%) were women, and 275 (65.2%) were men. When examining the distribution of patients according to the indications for latent tuberculosis infection treatment specified in the Ministry of Health's 2019 Tuberculosis Diagnosis and Treatment Guide, it was found that 6 (1.4%) patients were in contact with infectious cases, with 3 (50.0%) of these patients under 34 years old and 3 (50.0%) 35 years old or older. Prophylactic treatment was administered to 1 patient (33.3%) in the < 34 years age group. One patient with conversion was identified in the last 2 years, and it was noted that this patient received prophylaxis. Of the 153 patients with radiological findings compatible with tuberculosis sequelae, three (2.0%) received prophylaxis. According to the tuberculosis diagnosis and treatment guide, after adjusting for patients with common criteria, 164 (38.8%) patients were indicated for LTBI treatment. However, prophylaxis was only provided to 7 (4.2%) of these patients. The low rate of chemoprophylaxis observed in our study highlights the importance of diagnosing and monitoring LTBI. The data obtained will contribute to the diagnosis and treatment of LTBI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.